- Home
- Primary Care
- Upadacitinib Plus TCS Delivers Rapid and Sustained Relief in AD

5d3 min read
Medical Article
Introduction Atopic dermatitis (AD) is a chronic, inflammatory skin disease marked by intense pruritus, skin barrier disruption, and a cycle of flares and remissions. While topical corticosteroids (TCS) remain a cornerstone of treatment, many patients with moderate-to-severe disease fail to achieve adequate control. The advent of Janus kinase (JAK)

Upadacitinib Plus TCS Delivers Rapid and Sustained Relief in AD
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes